Search...
AUSTAR Life Science Technology released its interim results, with a profit attributable to shareholders of HKD 24.999 million, an increase of 325.37% year-on-year
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, AUSTAR released its interim results for the six months ended June 30, 2025, with revenue of 662 million yuan (RMB, the same below), a year-on-year decrease of 5.57%; profit attributable to shareholders was 24.99 million yuan, a year-on-year increase of 325.37%; basic earnings per share were 0.05 yuan
According to the Zhitong Finance APP, AUSTAR (06118) released its interim results for the six months ending June 30, 2025, with revenue of 662 million yuan (RMB, the same below), a year-on-year decrease of 5.57%; profit attributable to shareholders of 24.999 million yuan, a year-on-year increase of 325.37%; basic earnings per share of 0.05 yuan
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments